SCRIBE THERAPEUTICS INC. Shareholders' Equity
SCRIBE THERAPEUTICS INC. (SCTX) had Shareholders' Equity of -$164.85 million as of 2026-06-30, per its 10-Q filed 2026-09-02.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-02
- 2026-06-30: Stockholders' Equity Attributable to Parent -$164.85M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$158.74M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$143.42M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$137.88M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$164.85M 10-Q · filed 2026-09-02 |
| 2026-03-31 | -$158.74M 10-Q · filed 2026-09-02 |
| 2025-12-31 | -$143.42M 10-Q · filed 2026-09-02 |
| 2025-06-30 | -$137.88M 10-Q · filed 2026-09-02 |
| 2025-03-31 | -$128.67M 10-Q · filed 2026-09-02 |
| 2024-12-31 | -$125.86M 10-Q · filed 2026-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |